Fig. 2

Odds ratios for different COVID-19 symptoms in infected participants with AR who used SLIT and in infected participants with AR without SLIT. AR, allergic rhinitis; COVID-19, coronavirus disease 2019;Â SLIT, sublingual immunotherapy.

Odds ratios for different COVID-19 symptoms in infected participants with AR who used SLIT and in infected participants with AR without SLIT. AR, allergic rhinitis; COVID-19, coronavirus disease 2019;Â SLIT, sublingual immunotherapy.